MedTrace Logo

Preoperative Methylprednisolone in Endovascular Aortic Repair

NCT00989729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2014-11-14

No results posted yet for this study

Summary

The purpose of this study is to attenuate the systemic inflammatory response after Endovascular repair of abdominal aortic aneurysms, by administration of a single preoperative dosage of Methylprednisolone.

Conditions

  • Abdominal Aortic Aneurysms

Interventions

DRUG

Methylprednisolone

A single preoperative dosage 30 mg/kg Methylprednisolone suspended in physiological saline (100 ml in total) given intravenously as a 30 minute infusion, 2 hours before surgery.

DRUG

Physiological Saline

A single preoperative dosage 100 ml given intravenously as a 30 minute infusion, 2 hours before surgery

Sponsors & Collaborators

  • Louise de la Motte

    lead OTHER

Principal Investigators

  • Louise de la Motte, MD · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2013-01-31
Completion
2013-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00989729 on ClinicalTrials.gov